Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...

書誌詳細
主要な著者:	Holyoake, D, Partridge, M, Hurt, C, Mukherjee, S, Hawkins, M
フォーマット:	Conference item
出版事項:	Elsevier 2017

類似資料

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
著者:: Holyoake, DLP, 等
出版事項: (2018)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
著者:: Holyoake, D, 等
出版事項: (2016)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
著者:: Holyoake, D, 等
出版事項: (2017)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
著者:: Holyoake, D, 等
出版事項: (2019)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
著者:: Holyoake, D, 等
出版事項: (2018)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
著者:: Warren, S, 等
出版事項: (2016)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
著者:: Wilson, J, 等
出版事項: (2017)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
著者:: Witztum, A, 等
出版事項: (2016)

Pixel-based analysis of stomach dose-surface maps to improve toxicity predictions in gastrointestinal radiotherapy
著者:: Witztum, A, 等
出版事項: (2017)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
著者:: Warren, S, 等
出版事項: (2014)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
著者:: Warren, S, 等
出版事項: (2017)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
著者:: Holyoake, D, 等
出版事項: (2016)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
著者:: Holyoake, D
出版事項: (2018)

Modelling normal tissue toxicity in pancreatic chemoradiotherapy
著者:: Witztum, A
出版事項: (2018)

SU-F-T-108: Texture analysis for toxicity prediction from dose surface maps.
著者:: Witztum, A, 等
出版事項: (2016)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
著者:: Mukherjee, S, 等
出版事項: (2024)

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
著者:: Holyoake, D, 等
出版事項: (2016)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
著者:: Carrington, R, 等
出版事項: (2015)

Acute chemoradiotherapy toxicity in cervical cancer patients
著者:: Radojevic Marija Zivkovic, 等
出版事項: (2020-09-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
著者:: Warren, S, 等
出版事項: (2015)

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
著者:: Sara Broggi, 等
出版事項: (2023-01-01)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
著者:: Wilson, J, 等
出版事項: (2017)

The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
著者:: Min Chen, 等
出版事項: (2023-04-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
著者:: Chang Min Cho
出版事項: (2018-05-01)

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
著者:: Gulliford, S, 等
出版事項: (2010)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
著者:: Kuniaki Katsui, 等
出版事項: (2019-11-01)

ACUTE AND LATE TOXICITY WITH CHEMORADIOTHERAPY FOR OROPHARYNGEAL CANCER DEPENDING ON THE FRACTIONATION OPTION
著者:: Parkhomenko L. B.
出版事項: (2018-12-01)

Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy.
著者:: Jan-Niklas Becker, 等
出版事項: (2023-01-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
著者:: V. Yu. Skoropad, 等
出版事項: (2018-07-01)

Improper lung volume-dose parameters are risk factors for acute fatal radiation pneumonitis among esophageal cancer patients receiving chemoradiotherapy: a case-control study
著者:: Ruinuo Jia, 等
出版事項: (2025-01-01)

SU-D-BRA-06: Duodenal interfraction motion with abdominal compression.
著者:: Witztum, A, 等
出版事項: (2016)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
著者:: Kuniaki Katsui, 等
出版事項: (2020-07-01)

Primary diffuse large b-cell lymphoma of the stomach presenting as acute pancreatitis
著者:: Sara Ghani, 等
出版事項: (2020-06-01)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
著者:: Sebastian Zschaeck, 等
出版事項: (2017-01-01)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
著者:: Yoshiko Oshiro, 等
出版事項: (2021-07-01)

EP-1720: Impact of contouring variability on tumour control and normal tissue toxicity in liver SBRT
著者:: Robinson, M, 等
出版事項: (2016)

The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer
著者:: Bao-Zhong Zhang, 等
出版事項: (2023-01-01)

ECTOPIC PANCREATIC TISSUE IN THE STOMACH: CASE REPORT
著者:: Dejan Lukic, 等
出版事項: (2017-04-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
著者:: Guichao Li, 等
出版事項: (2013-01-01)

Evaluating the Predictive Value of the Dose-volume Parameters and Vascular Endothelial Growth Factor Expression on Rectal Toxicity in Prostate Cancer Patients
著者:: Marziyeh Mirzaeiyan, 等
出版事項: (2024-12-01)